DaVita
DVA
#2197
Rank
HK$65.33 B
Marketcap
HK$913.83
Share price
0.09%
Change (1 day)
-27.23%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$77.47

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$77.38. In 2024 the company made an earnings per share (EPS) of HK$85.86 an increase over its 2023 EPS that were of HK$59.24.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$77.47-9.78%
2024HK$85.8644.94%
2023HK$59.2427.26%
2022HK$46.55-35.56%
2021HK$72.2444.1%
2020HK$50.1319.7%
2019HK$41.88540.48%
2018HK$6.54-76.07%
2017HK$27.32-19.31%
2016HK$33.86242.52%
2015HK$9.89-62.87%
2014HK$26.6213.43%
2013HK$23.478.45%
2012HK$21.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
HK$114.43 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.78-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
HK$166.20 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$79.79 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA